TY  - JOUR
AU  - Teckie, Sewit
AU  - Solomon, Jeffrey
AU  - Kadapa, Karthik
AU  - Sanchez, Keisy
AU  - Orner, David
AU  - Kraus, Dennis
AU  - Kamdar, Dev P
AU  - Pereira, Lucio
AU  - Frank, Douglas
AU  - Diefenbach, Michael
PY  - 2021
DA  - 2021/3/19
TI  - A Mobile Patient-Facing App for Tracking Patient-Reported Outcomes in Head and Neck Cancer Survivors: Single-Arm Feasibility Study
JO  - JMIR Form Res
SP  - e24667
VL  - 5
IS  - 3
KW  - mHealth
KW  - ePROs
KW  - head and neck cancer
KW  - mobile phone
AB  - Background: Patients with head and neck cancer (HNC) frequently experience disease-related symptoms and treatment adverse effects that impact their overall quality of life. Cancer-specific mobile health apps for patient-related outcomes allow patients to communicate with their clinicians and proactively track their symptoms, which have been shown to improve clinical management and disease outcomes. Objective: The purpose of this study was to evaluate the feasibility of LogPAL, a novel iPhone-based mobile health app designed to help HNC survivors track and manage their posttreatment symptoms. Methods: Patients who completed curative treatment for HNC in the preceding 24 months were recruited from 2 clinical sites within a single institution. Upon enrollment, participants completed a brief sociodemographic survey, downloaded the app onto their iPhone devices, and were asked to complete a series of biweekly questionnaires (based on the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events) via the app for an 8-week study period. The primary feasibility endpoints included retention (retaining >80% of the enrolled participants for the duration of the study period), adherence (>50% of the participants completing 100% of the questionnaires over the study period), and usability (a mean system usability scale [SUS] score >68). Additional postintervention questions were collected to assess perceived usefulness, acceptance, and overall satisfaction. Results: Between January and October 2019, 38 participants were enrolled in the study. Three participants dropped out, and 3 were classified as nonusers. The remaining 32 (87%) were eligible for analysis. Their mean age was 57.8 (SD 12.3) years (range 24-77 years, 81% [26/32] male). Overall, 375 of 512 (73.2%) questionnaires were completed, with 17 (53%) of the 32 participants adherent. Participant-reported usability was acceptable; the mean SUS score was 71.9 (95% CI 64.3-79.5) with high satisfaction of LogPAL usefulness and likelihood to recommend to other cancer survivors. Conclusions: This single-arm prospective pilot study showed that LogPAL is a feasible, regularly used, accepted app for HNC survivors, justifying a full-scale pilot. Based on the findings from this study, future iterations will aim to improve usability and test intervention efficacy. 
SN  - 2561-326X
UR  - https://formative.jmir.org/2021/3/e24667
UR  - https://doi.org/10.2196/24667
UR  - http://www.ncbi.nlm.nih.gov/pubmed/33739291
DO  - 10.2196/24667
ID  - info:doi/10.2196/24667
ER  -